Task-specificity for Locomotor Recovery Following SCI
1 other identifier
interventional
17
1 country
1
Brief Summary
The primary goal of the proposed study is to identify the contributions of the amount of task-specific practice on locomotor (i.e., walking) recovery in patients with chronic (\> 1 yr) motor incomplete spinal cord injury (iSCI). Consistent with principles of motor learning and exercise physiology, the investigators contend that certain training (i.e., dosage) parameters of physical rehabilitation are critical to mobility outcomes following neurological injury. Specifically, the specificity, amount and intensity of physical interventions (i.e., practice) may influence specific outcomes in the patient population treated. In ambulatory patients with iSCI, there are very few studies that have controlled for or targeted these training variables or their influence on locomotor recovery. Previous work suggests these training parameters may influence locomotor recovery in patients with other neurological disorders (i.e., stroke), although few studies have attempted to delineate similar contributions of in iSCI. Indeed, no studies have carefully controlled the amount of task-specific practice during physical rehabilitation of patients with iSCI, and such interventions are rarely utilized in the clinical setting. The goal of the present study is to delineate the relative contributions of amount of task-specific training on locomotor outcomes in individuals with iSCI. Using a cross-over, randomized clinical trial design, the investigators anticipated non-specific (i.e., non-stepping) training activities would result in smaller improvements as compared to task-specific (stepping) training. The investigators will investigate the effects of such training on walking performance and kinematics, as well as the impairments thought to contribute to walking performance. Successful completion of this project could have an immediate impact on rehabilitation research and treatment of people following iSCI, and may be utilized to treat more subacute patients with iSCI or other acute-onset neurological disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2017
CompletedFirst Posted
Study publicly available on registry
May 8, 2017
CompletedStudy Start
First participant enrolled
July 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2020
CompletedFebruary 14, 2023
February 1, 2023
2 years
May 3, 2017
February 13, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Walking Speed
fastest comfortable walking speed over short distances
change in walking speed from baseline testing to post-testing following 6 weeks of training
Secondary Outcomes (1)
Walking Distance
change in walking speed from baseline testing to post-testing following 6 weeks of training
Study Arms (2)
Variable Stepping Training
EXPERIMENTALHigh intensity stepping training in multiple environments, including overground, on a treadmill and on stairs.
Variable Non-specific Training
ACTIVE COMPARATORHigh intensity non-stepping training, including balance, strength, and cycling tasks
Interventions
Six weeks (20 sessions) of high intensity stepping training in multiple variable environments
Six weeks (20 sessions) of high intensity stepping training in multiple variable environments
Eligibility Criteria
You may qualify if:
- individuals with chronic (\>1 yr duration) motor iSCI at the level or T10 (anatomical) or above
- ages 18-75 years
- ability to walk without physical assistance but with below-knee braces and assistive devices as needed
- self-selected gait speeds between 0.01-1.0 m/s.
- not currently receiving physical therapy
You may not qualify if:
- uncontrolled cardiopulmonary or metabolic disease that limits exercise participation
- active heterotopic ossification
- recurrent history of lower extremity fractures
- previous orthopedic or other peripheral or central neurological injury that may impair locomotor function
- history of botulinum toxin injection \< 3 months prior
- Patients who are prescribed intrathecal or oral anti-spastics should agree to limit changes in anti-spastic use throughout the training and testing period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rehabilitation Hospital of Indiana
Indianapolis, Indiana, 46254-2607, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Hornby
Indiana University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Blinded assessors at each measurement
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 3, 2017
First Posted
May 8, 2017
Study Start
July 1, 2017
Primary Completion
June 30, 2019
Study Completion
September 30, 2020
Last Updated
February 14, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share
Data available as requested